In a report released today, Phil Nadeau from TD Cowen maintained a Buy rating on Rhythm Pharmaceuticals (RYTM – Research Report), with a price ...

On Friday, TD Cowen's Bryan Bergin slapped a new 12-month price target on Mastercard of $567 per share, well up from his ...

TD Cowen lowered the firm’s price target on Nike (NKE) to $73 from $78 and keeps a Hold rating on the shares. The firm says meetings with ...

John Kernan, TD Cowen managing director and retail analyst, joins 'Money Movers' to discuss how important Chinese exposure is ...

Uncertainty about how US President-elect Donald Trump will apply tariffs has prompted an analyst at Toronto-Dominion Bank to ...

Life Science Tools and Diagnostics stocks are viewed favorably at TD Cowen despite concerns over Trump's policies and his HHS ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.19% of ...

On Friday, Xylem Inc (XYL) stock saw a modest uptick, ending the day at $121.78 which represents a slight increase of $0.15 or 0.12% from the prior close of $121.63. The stock opened at $121.73 and ...

Logistics professionals navigating their path forward face challenging market conditions, an evolving regulatory environment, a rapidly changing technology landscape, and an increasingly competitive ...

We recently compiled a list of the 13 AI News You Probably Missed. In this article, we are going to take a look at where ...

Onex Corp. shares are climbing after the Canadian investment firm shed its only neutral rating, with TD Cowen upgrading the ...